The tumor was localized to the bulbar conjunctiva in 25% of cases. Invasion onto the cornea was seen in 72%, onto the sclera in 5%, into the uvea in 1%, and into the orbit in 2% of the eyes.

Source: Raymond I. Cho, MD, FACS, and Emily Xu, MD Conjunctival melanoma most often presents as a pigmented or non-pigmented spot or raised mass on the bulbar, forniceal or palpebral conjunctiva.

Conjunctivochalasis (CCH) is characterized by loose and non-edematous folds of excess conjunctiva, generally in the inferior bulbar conjunctival area (Marmalidou and colleagues).

The treatment is administered as 1 drop into the conjunctival sac 2 to 4 times daily. During the first 24 to 48 hours, the dosing frequency may be increased to 1 application every 4 hours.